Madrigal Pharmaceuticals, Inc.(MDGL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MDGL Madrigal Pharmaceuticals, Inc.

休市中 07-11 16:00:00 EDT

315.46

+0.82

+0.26%

盘后315.46

+0.000.00%

17:25 EDT

最高316.97	最低309.62	成交量16.39万
今开311.88	昨收314.64	日振幅2.33%
总市值70.04亿	流通市值34.56亿	总股本2,220万
成交额5,155万	换手率1.50%	流通股本1,096万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MDGL","market":"US","secType":"STK","nameCN":"Madrigal Pharmaceuticals, Inc.","latestPrice":315.46,"timestamp":1752264000000,"preClose":314.64,"halted":0,"volume":163873,"hourTrading":{"tag":"盘后","latestPrice":315.46,"preClose":315.46,"latestTime":"17:25 EDT","volume":5199,"amount":1640074.02,"timestamp":1752269125344},"delay":0,"floatShares":10955139,"shares":22203282,"eps":-17.96659,"marketStatus":"休市中","change":0.82,"latestTime":"07-11 16:00:00 EDT","open":311.88,"high":316.965,"low":309.62,"amount":51554026.28512,"amplitude":0.023344,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-17.96659,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":314.64,"preHourTrading":{"tag":"盘前","latestPrice":315,"preClose":314.64,"latestTime":"09:19 EDT","volume":13,"amount":4093.99991,"timestamp":1752239982562},"postHourTrading":{"tag":"盘后","latestPrice":315.46,"preClose":315.46,"latestTime":"17:25 EDT","volume":5199,"amount":1640074.02,"timestamp":1752269125344},"volumeRatio":0.7601423124026987,"impliedVol":0.6938,"impliedVolPercentile":0.764},"requestUrl":"/m/hq/s/MDGL","defaultTab":"news","newsList":[{"id":"2550040326","title":"Madrigal Pharmaceuticals, Inc.7月10日成交额为5892.18万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550040326","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550040326?lang=zh_cn&edition=full","pubTime":"2025-07-11 11:42","pubTimestamp":1752205378,"startTime":"0","endTime":"0","summary":"美东时间2025年7月10日，Madrigal Pharmaceuticals, Inc.成交额为5892.18万美元，成交额较昨日减少45.00%，当日成交量为18.87万股。Madrigal Pharmaceuticals, Inc.于2025年7月10日涨1.96%，报314.64美元，该股过去5个交易日涨4.83%，年初至今涨1.97%，过去60日跌0.79%。该公司的药物 Rezdiffra  是一种每日一次、口服、肝脏靶向的甲状腺激素受体激动剂，旨在针对 MASH 的关键根本原因。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711114302a443d868&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711114302a443d868&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","MDGL","BK4139","BK4585"],"gpt_icon":0},{"id":"2550691999","title":"Madrigal Pharmaceuticals, Inc.7月9日成交额为1.07亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550691999","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550691999?lang=zh_cn&edition=full","pubTime":"2025-07-10 11:39","pubTimestamp":1752118785,"startTime":"0","endTime":"0","summary":"美东时间2025年7月9日，Madrigal Pharmaceuticals, Inc.成交额为1.07亿美元，成交额较昨日增加48.29%，当日成交量为35.20万股。Madrigal Pharmaceuticals, Inc.于2025年7月9日涨7.33%，报308.59美元，该股过去5个交易日涨2.81%，年初至今涨0.01%，过去60日涨0.4%。该公司的药物 Rezdiffra  是一种每日一次、口服、肝脏靶向的甲状腺激素受体激动剂，旨在针对 MASH 的关键根本原因。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710113952a4419d8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710113952a4419d8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4139","BK4588","MDGL"],"gpt_icon":0},{"id":"2550509798","title":"Madrigal Pharmaceuticals, Inc.7月8日成交额为7225.06万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550509798","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550509798?lang=zh_cn&edition=full","pubTime":"2025-07-09 11:37","pubTimestamp":1752032275,"startTime":"0","endTime":"0","summary":"美东时间2025年7月8日，Madrigal Pharmaceuticals, Inc.成交额为7225.06万美元，成交额较昨日增加40.22%，当日成交量为25.07万股。Madrigal Pharmaceuticals, Inc.于2025年7月8日跌0.57%，报287.52美元，该股过去5个交易日跌5.0%，年初至今跌6.82%，过去60日跌8.42%。该公司的药物 Rezdiffra  是一种每日一次、口服、肝脏靶向的甲状腺激素受体激动剂，旨在针对 MASH 的关键根本原因。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709113758a43f5865&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709113758a43f5865&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","BK4139","MDGL"],"gpt_icon":0},{"id":"2549596630","title":"Madrigal Pharmaceuticals, Inc.7月7日成交额为5152.84万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549596630","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549596630?lang=zh_cn&edition=full","pubTime":"2025-07-08 11:33","pubTimestamp":1751945638,"startTime":"0","endTime":"0","summary":"美东时间2025年7月7日，Madrigal Pharmaceuticals, Inc.成交额为5152.84万美元，成交额较昨日增加57.91%，当日成交量为17.78万股。Madrigal Pharmaceuticals, Inc.于2025年7月7日跌3.25%，报289.17美元，该股过去5个交易日跌3.85%，年初至今跌6.29%，过去60日跌4.5%。该公司的药物 Rezdiffra  是一种每日一次、口服、肝脏靶向的甲状腺激素受体激动剂，旨在针对 MASH 的关键根本原因。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708113404a69c34d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708113404a69c34d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","BK4585","MDGL"],"gpt_icon":0},{"id":"2548353706","title":"Madrigal Pharmaceuticals, Inc.7月3日成交额为3263.19万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548353706","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548353706?lang=zh_cn&edition=full","pubTime":"2025-07-04 11:40","pubTimestamp":1751600407,"startTime":"0","endTime":"0","summary":"美东时间2025年7月3日，Madrigal Pharmaceuticals, Inc.成交额为3263.19万美元，成交额较昨日减少68.60%，当日成交量为10.87万股。Madrigal Pharmaceuticals, Inc.于2025年7月3日跌0.43%，报298.87美元，该股过去5个交易日跌0.21%，年初至今跌3.14%，过去60日跌3.75%。该公司的药物 Rezdiffra  是一种每日一次、口服、肝脏靶向的甲状腺激素受体激动剂，旨在针对 MASH 的关键根本原因。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704114012a72defea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704114012a72defea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","MDGL","BK4585"],"gpt_icon":0},{"id":"2548082574","title":"Madrigal Pharmaceuticals, Inc.7月2日成交额为1.04亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548082574","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548082574?lang=zh_cn&edition=full","pubTime":"2025-07-03 11:39","pubTimestamp":1751513997,"startTime":"0","endTime":"0","summary":"美东时间2025年7月2日，Madrigal Pharmaceuticals, Inc.成交额为1.04亿美元，成交额较昨日增加59.88%，当日成交量为34.09万股。Madrigal Pharmaceuticals, Inc.于2025年7月2日涨0.0%，报300.15美元，该股过去5个交易日涨8.11%，年初至今跌2.73%，过去60日跌4.53%。该公司的药物 Rezdiffra  是一种每日一次、口服、肝脏靶向的甲状腺激素受体激动剂，旨在针对 MASH 的关键根本原因。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703114005a4cc69c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703114005a4cc69c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","MDGL","BK4585"],"gpt_icon":0},{"id":"2548856581","title":"Madrigal Pharmaceuticals, Inc.7月1日成交额为6500.09万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548856581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548856581?lang=zh_cn&edition=full","pubTime":"2025-07-02 11:36","pubTimestamp":1751427386,"startTime":"0","endTime":"0","summary":"美东时间2025年7月1日，Madrigal Pharmaceuticals, Inc.成交额为6500.09万美元，成交额较昨日减少20.98%，当日成交量为21.79万股。Madrigal Pharmaceuticals, Inc.于2025年7月1日跌0.82%，报300.16美元，该股过去5个交易日涨5.33%，年初至今跌2.73%，过去60日跌8.24%。该公司的药物 Rezdiffra  是一种每日一次、口服、肝脏靶向的甲状腺激素受体激动剂，旨在针对 MASH 的关键根本原因。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702113630a4ca3806&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702113630a4ca3806&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","MDGL","BK4139","BK4588"],"gpt_icon":0},{"id":"2548025608","title":"Madrigal Pharmaceuticals, Inc.6月30日成交额为8226.17万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548025608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548025608?lang=zh_cn&edition=full","pubTime":"2025-07-01 11:22","pubTimestamp":1751340179,"startTime":"0","endTime":"0","summary":"美东时间2025年6月30日，Madrigal Pharmaceuticals, Inc.成交额为8226.17万美元，成交额较昨日减少49.70%，当日成交量为27.13万股。Madrigal Pharmaceuticals, Inc.于2025年6月30日涨0.63%，报302.64美元，该股过去5个交易日涨6.94%，年初至今跌1.92%，过去60日跌9.55%。该公司的药物 Rezdiffra  是一种每日一次、口服、肝脏靶向的甲状腺激素受体激动剂，旨在针对 MASH 的关键根本原因。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701112309a4c7f378&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701112309a4c7f378&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","MDGL","BK4139","BK4588"],"gpt_icon":0},{"id":"2546611732","title":"Madrigal Pharmaceuticals, Inc.6月24日成交额为8511.67万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546611732","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546611732?lang=zh_cn&edition=full","pubTime":"2025-06-25 11:36","pubTimestamp":1750822587,"startTime":"0","endTime":"0","summary":"美东时间2025年6月24日，Madrigal Pharmaceuticals, Inc.成交额为8511.67万美元，成交额较昨日增加0.57%，当日成交量为29.81万股。Madrigal Pharmaceuticals, Inc.于2025年6月24日涨0.7%，报284.98美元，该股过去5个交易日跌0.03%，年初至今跌7.64%，过去60日跌15.5%。该公司的药物 Rezdiffra  是一种每日一次、口服、肝脏靶向的甲状腺激素受体激动剂，旨在针对 MASH 的关键根本原因。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625113632a4bc8ac1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625113632a4bc8ac1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDGL","BK4139","BK4588","BK4585"],"gpt_icon":0},{"id":"2545000475","title":"Madrigal Pharmaceuticals, Inc.6月23日成交额为8463.65万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545000475","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545000475?lang=zh_cn&edition=full","pubTime":"2025-06-24 11:35","pubTimestamp":1750736140,"startTime":"0","endTime":"0","summary":"美东时间2025年6月23日，Madrigal Pharmaceuticals, Inc.成交额为8463.65万美元，成交额较昨日减少20.81%，当日成交量为30.01万股。Madrigal Pharmaceuticals, Inc.于2025年6月23日跌0.96%，报282.99美元，该股过去5个交易日跌4.26%，年初至今跌8.29%，过去60日跌15.23%。该公司的药物 Rezdiffra  是一种每日一次、口服、肝脏靶向的甲状腺激素受体激动剂，旨在针对 MASH 的关键根本原因。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624113543a4bab2c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624113543a4bab2c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","MDGL","BK4139","BK4588"],"gpt_icon":0},{"id":"2545104020","title":"Madrigal Pharmaceuticals, Inc.6月20日成交额为1.07亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545104020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545104020?lang=zh_cn&edition=full","pubTime":"2025-06-21 11:33","pubTimestamp":1750476829,"startTime":"0","endTime":"0","summary":"美东时间2025年6月20日，Madrigal Pharmaceuticals, Inc.成交额为1.07亿美元，成交额较昨日增加24.37%，当日成交量为37.48万股。Madrigal Pharmaceuticals, Inc.于2025年6月20日涨1.06%，报285.73美元，该股过去5个交易日跌3.86%，年初至今跌7.4%，过去60日跌16.77%。该公司的药物 Rezdiffra  是一种每日一次、口服、肝脏靶向的甲状腺激素受体激动剂，旨在针对 MASH 的关键根本原因。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621113356a7158e50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250621113356a7158e50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","MDGL","BK4585","BK4139"],"gpt_icon":0},{"id":"2544467135","title":"Madrigal Pharmaceuticals, Inc.6月18日成交额为8593.19万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544467135","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544467135?lang=zh_cn&edition=full","pubTime":"2025-06-19 11:27","pubTimestamp":1750303654,"startTime":"0","endTime":"0","summary":"美东时间2025年6月18日，Madrigal Pharmaceuticals, Inc.成交额为8593.19万美元，成交额较昨日增加39.84%，当日成交量为30.37万股。Madrigal Pharmaceuticals, Inc.于2025年6月18日涨1.12%，报282.72美元，该股过去5个交易日跌3.95%，年初至今跌8.38%，过去60日跌18.38%。该公司的药物 Rezdiffra  是一种每日一次、口服、肝脏靶向的甲状腺激素受体激动剂，旨在针对 MASH 的关键根本原因。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619112744a711afe0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619112744a711afe0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4585","MDGL","BK4139"],"gpt_icon":0},{"id":"2544522939","title":"Madrigal Pharmaceuticals, Inc.6月16日成交额为9568.12万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544522939","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544522939?lang=zh_cn&edition=full","pubTime":"2025-06-17 11:35","pubTimestamp":1750131335,"startTime":"0","endTime":"0","summary":"美东时间2025年6月16日，Madrigal Pharmaceuticals, Inc.成交额为9568.12万美元，成交额较昨日增加19.87%，当日成交量为33.29万股。Madrigal Pharmaceuticals, Inc.于2025年6月16日跌3.56%，报285.06美元，该股过去5个交易日涨1.72%，年初至今跌7.62%，过去60日跌14.94%。该公司的药物 Rezdiffra  是一种每日一次、口服、肝脏靶向的甲状腺激素受体激动剂，旨在针对 MASH 的关键根本原因。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617113544a70d667e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617113544a70d667e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","MDGL","BK4585"],"gpt_icon":0},{"id":"2543652170","title":"Madrigal Pharmaceuticals, Inc.6月13日成交额为7982.13万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543652170","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543652170?lang=zh_cn&edition=full","pubTime":"2025-06-14 11:26","pubTimestamp":1749871565,"startTime":"0","endTime":"0","summary":"美东时间2025年6月13日，Madrigal Pharmaceuticals, Inc.成交额为7982.13万美元，成交额较昨日减少28.89%，当日成交量为27.07万股。Madrigal Pharmaceuticals, Inc.于2025年6月13日跌0.55%，报295.57美元，该股过去5个交易日涨6.23%，年初至今跌4.21%，过去60日跌13.26%。该公司的药物 Rezdiffra  是一种每日一次、口服、肝脏靶向的甲状腺激素受体激动剂，旨在针对 MASH 的关键根本原因。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614112606a4a89ac0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614112606a4a89ac0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4585","BK4588","MDGL"],"gpt_icon":0},{"id":"2542256334","title":"Madrigal Pharmaceuticals, Inc.6月11日成交额为1.22亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542256334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542256334?lang=zh_cn&edition=full","pubTime":"2025-06-12 11:16","pubTimestamp":1749698190,"startTime":"0","endTime":"0","summary":"美东时间2025年6月11日，Madrigal Pharmaceuticals, Inc.成交额为1.22亿美元，成交额较昨日增加201.69%，当日成交量为41.80万股。Madrigal Pharmaceuticals, Inc.于2025年6月11日涨4.26%，报294.34美元，该股过去5个交易日涨5.38%，年初至今跌4.61%，过去60日跌14.05%。该公司的药物 Rezdiffra  是一种每日一次、口服、肝脏靶向的甲状腺激素受体激动剂，旨在针对 MASH 的关键根本原因。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612111633a7047d72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612111633a7047d72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","MDGL","BK4139","BK4588"],"gpt_icon":0},{"id":"2542301373","title":"Madrigal Pharmaceuticals, Inc.6月10日成交额为4057.21万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542301373","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542301373?lang=zh_cn&edition=full","pubTime":"2025-06-11 11:03","pubTimestamp":1749611005,"startTime":"0","endTime":"0","summary":"美东时间2025年6月10日，Madrigal Pharmaceuticals, Inc.成交额为4057.21万美元，成交额较昨日减少53.19%，当日成交量为14.34万股。Madrigal Pharmaceuticals, Inc.于2025年6月10日涨0.74%，报282.32美元，该股过去5个交易日跌0.73%，年初至今跌8.51%，过去60日跌18.96%。该公司的药物 Rezdiffra  是一种每日一次、口服、肝脏靶向的甲状腺激素受体激动剂，旨在针对 MASH 的关键根本原因。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611110326a4a2cfb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611110326a4a2cfb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MDGL","BK4588","BK4585"],"gpt_icon":0},{"id":"2542368064","title":"Madrigal Pharmaceuticals, Inc.6月9日成交额为8667.07万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542368064","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542368064?lang=zh_cn&edition=full","pubTime":"2025-06-10 11:00","pubTimestamp":1749524413,"startTime":"0","endTime":"0","summary":"美东时间2025年6月9日，Madrigal Pharmaceuticals, Inc.成交额为8667.07万美元，成交额较昨日增加11.49%，当日成交量为31.05万股。Madrigal Pharmaceuticals, Inc.于2025年6月9日涨0.72%，报280.24美元，该股过去5个交易日涨2.78%，年初至今跌9.18%，过去60日跌13.24%。该公司的药物 Rezdiffra  是一种每日一次、口服、肝脏靶向的甲状腺激素受体激动剂，旨在针对 MASH 的关键根本原因。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610110014a4a14170&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610110014a4a14170&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MDGL","BK4139","BK4585","BK4588"],"gpt_icon":0},{"id":"2541886726","title":"Madrigal Pharmaceuticals, Inc.6月5日成交额为8071.29万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541886726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541886726?lang=zh_cn&edition=full","pubTime":"2025-06-06 11:02","pubTimestamp":1749178972,"startTime":"0","endTime":"0","summary":"美东时间2025年6月5日，Madrigal Pharmaceuticals, Inc.成交额为8071.29万美元，成交额较昨日增加25.18%，当日成交量为29.25万股。Madrigal Pharmaceuticals, Inc.于2025年6月5日跌1.87%，报274.1美元，该股过去5个交易日涨1.54%，年初至今跌11.17%，过去60日跌18.27%。该公司的药物 Rezdiffra  是一种每日一次、口服、肝脏靶向的甲状腺激素受体激动剂，旨在针对 MASH 的关键根本原因。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606110255a49c44d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250606110255a49c44d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4588","BK4139","MDGL"],"gpt_icon":0},{"id":"2540087934","title":"Madrigal Pharmaceuticals, Inc.6月3日成交额为1.13亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540087934","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540087934?lang=zh_cn&edition=full","pubTime":"2025-06-04 10:59","pubTimestamp":1749005965,"startTime":"0","endTime":"0","summary":"美东时间2025年6月3日，Madrigal Pharmaceuticals, Inc.成交额为1.13亿美元，成交额较昨日增加43.18%，当日成交量为40.51万股。Madrigal Pharmaceuticals, Inc.于2025年6月3日涨4.31%，报284.41美元，该股过去5个交易日涨4.73%，年初至今跌7.83%，过去60日跌14.18%。该公司的药物 Rezdiffra  是一种每日一次、口服、肝脏靶向的甲状腺激素受体激动剂，旨在针对 MASH 的关键根本原因。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604105927a4992ded&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604105927a4992ded&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","MDGL","BK4139","BK4585"],"gpt_icon":0},{"id":"2540743229","title":"Madrigal Pharmaceuticals, Inc.6月2日成交额为7883.65万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540743229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540743229?lang=zh_cn&edition=full","pubTime":"2025-06-03 10:56","pubTimestamp":1748919361,"startTime":"0","endTime":"0","summary":"美东时间2025年6月2日，Madrigal Pharmaceuticals, Inc.成交额为7883.65万美元，成交额较昨日减少11.78%，当日成交量为28.79万股。Madrigal Pharmaceuticals, Inc.于2025年6月2日跌0.94%，报272.67美元，该股过去5个交易日涨1.91%，年初至今跌11.63%，过去60日跌17.06%。该公司的药物 Rezdiffra  是一种每日一次、口服、肝脏靶向的甲状腺激素受体激动剂，旨在针对 MASH 的关键根本原因。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603105606a6f7e89d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250603105606a6f7e89d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","MDGL","BK4585"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.madrigalpharma.com","stockEarnings":[{"period":"1week","weight":0.0555},{"period":"1month","weight":0.0718},{"period":"3month","weight":-0.0053},{"period":"6month","weight":-0.0692},{"period":"1year","weight":0.0866},{"period":"ytd","weight":0.0223}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Madrigal Pharmaceuticals, Inc.于2000年3月成立并在2001年7月开始运营。 Synta制药公司是一家生物制药公司，致力于发现、开发和商业化小分子药物以扩大和加强带有严重疾病的患者的生命，包括癌症和慢性症性疾病。该公司有两种候选药物在临床实验中用于治疗多种类型的癌症和几个用于临床前研究阶段的候选药物。所有公司的候选药物利用公司的专利、独特的化合物和集成的发现引擎发现。这家公司保留了其候选药物的全部选择权。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.038123},{"month":2,"riseRate":0.777778,"avgChangeRate":0.080513},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.037813},{"month":4,"riseRate":0.555556,"avgChangeRate":0.008622},{"month":5,"riseRate":0.333333,"avgChangeRate":0.130548},{"month":6,"riseRate":0.666667,"avgChangeRate":0.032539},{"month":7,"riseRate":0.222222,"avgChangeRate":-0.074185},{"month":8,"riseRate":0.555556,"avgChangeRate":0.058165},{"month":9,"riseRate":0.333333,"avgChangeRate":0.13282},{"month":10,"riseRate":0.666667,"avgChangeRate":0.070394},{"month":11,"riseRate":0.555556,"avgChangeRate":0.062808},{"month":12,"riseRate":0.444444,"avgChangeRate":0.416281}],"exchange":"NASDAQ","name":"Madrigal Pharmaceuticals, Inc.","nameEN":"Madrigal Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Madrigal Pharmaceuticals, Inc.(MDGL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Madrigal Pharmaceuticals, Inc.(MDGL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Madrigal Pharmaceuticals, Inc.,MDGL,Madrigal Pharmaceuticals, Inc.股票,Madrigal Pharmaceuticals, Inc.股票老虎,Madrigal Pharmaceuticals, Inc.股票老虎国际,Madrigal Pharmaceuticals, Inc.行情,Madrigal Pharmaceuticals, Inc.股票行情,Madrigal Pharmaceuticals, Inc.股价,Madrigal Pharmaceuticals, Inc.股市,Madrigal Pharmaceuticals, Inc.股票价格,Madrigal Pharmaceuticals, Inc.股票交易,Madrigal Pharmaceuticals, Inc.股票购买,Madrigal Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Madrigal Pharmaceuticals, Inc.(MDGL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Madrigal Pharmaceuticals, Inc.(MDGL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}